Journal Articles

Evidence in wound care: the recent NICE guidance on Debrisoft monofilament debridement pad for use in acute or chronic wounds

Share this article

Acute wounds, Burns, Complex wounds, Diabetic foot ulcers, Editorial, Events, Exudate management, How to guides, Infection and biofilm, Leg ulcers, Lymphoedema, Moisture lesions, Palliative care, Pressure ulcers, Products, Professional development, Research, Serivice delivery, Skin integrity, Societies, Supplements, Surgical wounds, Wellbeing and concordance, Wound assessment

Evidence in wound care: the recent NICE guidance on Debrisoft monofilament debridement pad for use in acute or chronic wounds

Omar Ali, Patricia Grocott, Richard White, Trudie Young

28 June 2014

It is highly likely that we have seen a significant change in the attitude to evidence when related to wound care products. In March, the National Institute for Health and Care Excellence (NICE) released medical technology guidance on wound debridement (NICE, 2014). There are important issues associated with this, not least the level of clinical evidence that NICE acknowledged in making this recommendation.

↓ Download pdf